5ARIs

May 26, 2017

Αlpha Blocker Isn’t Necessary in LUTS Patients Using 5ARIs, But Switch May Need Care, Study Suggests

News

Patients being treated with a combination 5-alpha reductase inhibitor (5ARIs) and an alpha blocker may switch to 5ARIs alone with no worsening of lower urinary tract symptoms (LUTS), a new study ... Read more

January 11, 2017

Combination Therapy Significantly Improved BPH Symptoms in Men, Study Finds

News

A combination therapy composed of a 5-alpha-reductase inhibitor and an alpha-blocker provides significant improvements in men with benign prostatic hyperplasia (BPH), according to a new study. But a high percentage ... Read more

March 23, 2016March 23, 2016

Hormone-Blocking Drug Reported to Markedly Ease Bleeding in BPH Patients Undergoing TURP

News

Researchers at Tanta University, Egypt, report that goserelin acetate, a drug inducing the luteinising hormone-releasing hormone, reduces blood loss during transurethral resection of the prostate (TURP) in patients with benign ... Read more

March 17, 2016March 17, 2016

Most BPH Patients Receive One Therapy Despite Studies Showing Combo Therapy Appears Superior

News

Despite evidence from randomized controlled trials showing that combination therapy has better efficacy in patients with benign prostatic hyperplasia (BPH), a population-based study found that monotherapy with alpha-blockers or 5alpha-reductase ... Read more